Altacor is an ophthalmic specialty pharmaceutical company with a portfolio of marketed and development products. The company differentiates its development products primarily through formulation or reprofiling existing compounds with established clinical activity and systemic safety. The products are focused in the following sub-therapeutic areas: ocular surface disease and surgical.
Altacor markets numerous products in the UK and Ireland (Clinitas®, Clinitas® OTC range, Clinitas® Hot Eye Compress and BioLon®) which are commercialised through its own sales and marketing organisation and network. Clinitas®, Clinitas® Multi and Clinitas GEL are prescription products, including preservative free options. Clinitas products can be used for moderate dry eye conditions and have the highest concentration of hyaluronic acid (0.4%) in the UK. BioLon® is high quality viscoelastic for use in cataract surgery with convenient 6 month room temperature storage. The company is actively pursuing European expansion.
Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 19, 2012 | Clinitas ensures no dry eyes at this year's Christmas party! | Clinitas ensures no dry eyes at this year's Christmas party! 19-12-2012 Alcohol the night before work could cause dry eye symptoms New evidence suggests that alcohol leaves behind more than just a sore head. A recent study has shown the deh... |
| Nov 24, 2011 | Altacor expands as Clinitas gains greater formulary acceptance | Altacor expands as Clinitas gains greater formulary acceptance 24-11-2011 Altacor, the specialist ophthalmology company, is expanding. It has appointed two experienced product specialists to help drive awareness of its Clinitas dry-eye trea... |
| Sep 1, 2011 | TLC for the real causes of dry eye | TLC for the real causes of dry eye 01-09-2011 Computer users with uncomfortable eyes will be given some TLC (tear layer care) by Altacor, a specialist ophthalmic pharmaceutical company, at a ‘mingle’ at St John’s Innovation Centre. The comp... |
| Feb 9, 2011 | Altacor Closes £1.9M Funding | Altacor, a Cambridge, UK-based ophthalmic specialty pharmaceutical company, has closed a £1.9m second tranche of a £3.4m round. This tranche was led by NVM Private Equity, with participation from Enterprise Ventures and Beringea. The compan... |
Reviews 0
FAQ about Altacor
When was Altacor founded?
Altacor was founded in 2007.
How much funding has Altacor raised?
Altacor has raised $3.05M in total across 1 funding round.
What has the press written about Altacor?
Parsers VC has collected 5 articles mentioning Altacor, among them “Clinitas ensures no dry eyes at this year's Christmas party!” (Dec 19, 2012) and “Altacor expands as Clinitas gains greater formulary acceptance” (Nov 24, 2011).
Is Altacor still active?
Yes, Altacor is active; its latest activity on Parsers VC dates from Aug 15, 2014.